BRCA Mutation Risk Underestimated by BRCAPRO Model
More mutations observed than expected at BRCAPRO scores of less than 40%.
Diagnosis & Disease Information
FDA Panel Recommends HPV Test That Could Replace Pap
Experts voted 13-0 that Roche’s test was safe and effective as first step in cervical cancer screening.
Some Women Overestimate Ovarian Cancer Risk
More than one-third of postmenopausal women estimate their risk of ovarian cancer to be at least 50%.
Erlotinib Plus Cisplatin Chemoradiation Promising for Cervical Cancer
Researchers found a complete response for 94.4% of women with locally advanced cervical cancer treated with erlotinib and cisplatin-based chemoradiation.
New Study May Pave Way for Detecting Ovarian Cancer Earlier
Research has revealed new genetic variants in patients with ovarian cancer that may eventually help detect the disease earlier.
Bevacizumab Plus Chemo Prolongs Survival in Advanced Cervical Cancer
Patients given bevacizumab survived almost 4 months longer than controls, but had a higher rate of adverse events.
HPV Vaccination Cuts Cervical Lesion Risk
HPV vaccination is associated with reduced risk of atypic, atypia+ or cervical intraepithelial neoplasia grade 2 or 3.
Earlier Ovary Removal Better for BRCA Carriers
Oophorectomy reduces the risk of developing ovarian, fallopian tube, or peritoneal cancer by 70% in women with BRCA mutations.
Bevacizumab Improves Survival in Cervical Cancer
Adjuvant bevacizumab increases overall survival in cervical cancer and improves progression-free survival in glioblastoma.
Vitamin C May Kill Ovarian Cancer Cells
Millimolar ascorbate induces pro-oxidant effects and boosts chemotherapeutic agents in mouse model.
- Loading...
Loading...
Next post in Gynecologic Cancer
Loading... 
Loading...